Koers BioLargo, Inc. Other OTC
Aandelen
BLGO
US09065A1007
Chemische grondstoffen
Omzet 2024 * | 19,05 mln. 17,81 mln. | Omzet 2025 * | 25,76 mln. 24,1 mln. | Marktkapitalisatie | 104 mln. 97,58 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -1 mln. -935K | Nettowinst (verlies) 2025 * | - 0 | EV/omzet 2024 * | 5,48 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 4,05 x |
K/w-verhouding 2024 * |
-35,3
x | K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 85,75% |
Recentste transcriptie over BioLargo, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 01-06-02 |
Director of Finance/CFO | 68 | 01-02-08 | |
Chief Operating Officer | 55 | 01-06-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 28-04-06 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 01-04-07 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 01-06-02 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,14% | 103 mld. | |
-5,63% | 63,04 mld. | |
+39,52% | 39,06 mld. | |
+12,91% | 37,58 mld. | |
+7,41% | 33,24 mld. | |
+6,85% | 19,22 mld. | |
+12,86% | 16,83 mld. | |
+7,73% | 15,03 mld. | |
+16,93% | 14,96 mld. |